Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
REEP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM50B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB40B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PFAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSU72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UQCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on